| Primary |
| Drug Use For Unknown Indication |
28.6% |
| Dyspepsia |
17.9% |
| Product Used For Unknown Indication |
14.3% |
| Calcium Deficiency |
7.1% |
| Gastric Ulcer |
7.1% |
| Pruritus |
7.1% |
| Stomach Discomfort |
7.1% |
| Chest Discomfort |
3.6% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Prophylaxis |
3.6% |
|
| Nephrolithiasis |
16.0% |
| Myocardial Infarction |
8.0% |
| Overdose |
8.0% |
| Convulsion |
4.0% |
| Drug Administration Error |
4.0% |
| Drug Dependence |
4.0% |
| Haemorrhage |
4.0% |
| Hiccups |
4.0% |
| Melaena |
4.0% |
| Milk-alkali Syndrome |
4.0% |
| Pain In Extremity |
4.0% |
| Pancreatitis Acute |
4.0% |
| Parkinsonism |
4.0% |
| Patellofemoral Pain Syndrome |
4.0% |
| Premature Baby |
4.0% |
| Rectal Haemorrhage |
4.0% |
| Renal Disorder |
4.0% |
| Stomach Discomfort |
4.0% |
| Throat Tightness |
4.0% |
| Toe Deformity |
4.0% |
|
| Secondary |
| Drug Exposure During Pregnancy |
19.1% |
| Drug Use For Unknown Indication |
17.5% |
| Product Used For Unknown Indication |
12.0% |
| Gastrooesophageal Reflux Disease |
9.8% |
| Dyspepsia |
6.0% |
| Abdominal Pain Upper |
3.8% |
| Depression |
3.8% |
| Flatulence |
3.8% |
| Maternal Exposure Timing Unspecified |
3.8% |
| Blood Cholesterol Increased |
2.7% |
| Diabetes Mellitus |
2.7% |
| Hypertension |
2.2% |
| Nausea |
2.2% |
| Peritoneal Dialysis |
2.2% |
| Blood Calcium Decreased |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Blood Glucose Increased |
1.1% |
| Cardiac Failure Congestive |
1.1% |
| Chest Pain |
1.1% |
|
| Drug Ineffective |
11.6% |
| Tachypnoea |
11.6% |
| Vomiting |
11.6% |
| Nausea |
9.3% |
| Weight Decreased |
9.3% |
| Dyspepsia |
4.7% |
| Intentional Drug Misuse |
4.7% |
| Overdose |
4.7% |
| Palpitations |
4.7% |
| Wrong Technique In Drug Usage Process |
4.7% |
| Blood Parathyroid Hormone Increased |
2.3% |
| Drug Exposure During Pregnancy |
2.3% |
| Eructation |
2.3% |
| Exposure During Pregnancy |
2.3% |
| Gastric Disorder |
2.3% |
| Gastrointestinal Disorder |
2.3% |
| Haemorrhage |
2.3% |
| Headache |
2.3% |
| Heart Disease Congenital |
2.3% |
| Hypotension |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Drug Use For Unknown Indication |
24.4% |
| Gastrooesophageal Reflux Disease |
12.3% |
| Pain |
5.9% |
| Dyspepsia |
4.3% |
| Hypertension |
3.6% |
| Crohn's Disease |
2.8% |
| Osteoporosis |
2.7% |
| Depression |
2.6% |
| Rheumatoid Arthritis |
2.5% |
| Peritoneal Dialysis |
1.6% |
| Nausea |
1.6% |
| Anxiety |
1.5% |
| Constipation |
1.5% |
| Insomnia |
1.5% |
| Diabetes Mellitus |
1.3% |
| Asthma |
1.3% |
| Arthritis |
1.2% |
| Multiple Myeloma |
1.2% |
| Prophylaxis |
1.0% |
|
| Vomiting |
16.9% |
| Weight Decreased |
11.4% |
| Vitamin D Deficiency |
9.1% |
| Weight Increased |
7.1% |
| Osteoporosis |
6.4% |
| Urinary Tract Infection |
5.0% |
| Pneumonia |
4.2% |
| Nausea |
3.9% |
| Therapeutic Response Decreased |
3.9% |
| Wrist Fracture |
3.9% |
| Wheezing |
3.8% |
| White Blood Cell Count Decreased |
3.4% |
| Pyrexia |
3.3% |
| Ventricular Septal Defect |
2.9% |
| Drug Ineffective |
2.6% |
| Pain |
2.6% |
| Peritonitis Bacterial |
2.4% |
| Upper Limb Fracture |
2.4% |
| Thrombosis |
2.3% |
| Vision Blurred |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Gastrooesophageal Reflux Disease |
6.5% |
| Abdominal Pain Upper |
4.3% |
| Flatulence |
4.3% |
| Hypertension |
4.3% |
| Nausea |
4.3% |
| Oropharyngeal Pain |
4.3% |
| Pain |
4.3% |
| Smoking Cessation Therapy |
4.3% |
| Tongue Ulceration |
4.3% |
| Convulsion |
2.2% |
| Heart Rate Increased |
2.2% |
| Laryngitis |
2.2% |
| Plasma Cell Myeloma |
2.2% |
|
| International Normalised Ratio Decreased |
25.0% |
| Nephrolithiasis |
25.0% |
| Dysarthria |
12.5% |
| Heart Rate Irregular |
12.5% |
| Potentiating Drug Interaction |
12.5% |
| Skin Exfoliation |
12.5% |
|
